• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Article

LHA serves multiple roles in acne management

Paris - A new cosmetic product incorporating beta-lipohydroxyacid (LHA), a lipophilic derivative of salicylic acid, appears to be usefulwhen used alone for preventing relapses in patients who have responded toacne treatment and as an adjunct to topical tretinoin for improving thetolerability of the retinoid and shortening the onset to efficacy, accordingto results of prospective, randomized, double-blind studies presented byBrigitte Dréno, M.D., at the World Congress of Dermatology.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

© 2025 MJH Life Sciences

All rights reserved.